{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:47:14Z","timestamp":1787064434347,"version":"build-2736575974"},"reference-count":14,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.urolonc.2024.01.006","type":"journal-article","created":{"date-parts":[[2024,1,18]],"date-time":"2024-01-18T04:38:49Z","timestamp":1705552729000},"page":"160.e25-160.e31","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Age related trends in the utilization of neoadjuvant chemotherapy for muscle invasive bladder cancer"],"prefix":"10.1016","volume":"42","author":[{"given":"Abigail","family":"Kohut-Jackson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Orf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominic","family":"Barresi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Facundo","family":"Davaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2587-0865","authenticated-orcid":false,"given":"Zachary","family":"Hamilton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2024.01.006_bib0001","unstructured":"Cancer of the urinary bladder - cancer stat facts [Internet]. Seer. [cited August 29, 2023]. Available from: https:\/\/seer.cancer.gov\/statfacts\/html\/urinb.html"},{"key":"10.1016\/j.urolonc.2024.01.006_bib0002","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1056\/NEJMoa022148","article-title":"Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer","volume":"349","author":"Grossman","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.urolonc.2024.01.006_bib0003","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.urology.2013.07.072","article-title":"Trends in the utilization of neoadjuvant chemotherapy in muscle-invasive bladder cancer: results from the national cancer database","volume":"83","author":"Zaid","year":"2014","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2024.01.006_bib0004","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1007\/s00345-018-2584-0","article-title":"Impact of neoadjuvant chemotherapy on short-term complications and survival following radical cystectomy","volume":"37","author":"Milenkovic","year":"2019","journal-title":"World J Urol"},{"key":"10.1016\/j.urolonc.2024.01.006_bib0005","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.eururo.2014.01.014","article-title":"The effect of neoadjuvant chemotherapy on perioperative outcomes in patients who have bladder cancer treated with radical cystectomy: a population-based study","volume":"66","author":"Gandaglia","year":"2014","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.urolonc.2024.01.006_bib0006","first-page":"21","article-title":"Use of neoadjuvant chemotherapy in elderly patients with muscle-invasive bladder cancer: a population-based study, 2006-2017","volume":"36","author":"Posielski","year":"2022","journal-title":"Oncology"},{"key":"10.1016\/j.urolonc.2024.01.006_bib0007","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1093\/annonc\/mdi039","article-title":"The outcome of elderly patients with advanced urothelial carcinoma after platinum-based combination chemotherapy","volume":"16","author":"Bamias","year":"2005","journal-title":"Ann Oncol"},{"key":"10.1016\/j.urolonc.2024.01.006_bib0008","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1001\/jamaoncol.2016.6905","article-title":"Using the National Cancer Database for outcomes research: a review","volume":"3","author":"Boffa","year":"2017","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.urolonc.2024.01.006_bib0009","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.eururo.2005.04.006","article-title":"neoadjuvant chemotherapy in invasive bladder cancer: update of a systematic review and meta-analysis of individual patient data: advanced bladder cancer (ABC) meta-analysis collaboration","volume":"48","author":"Vale","year":"2005","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2024.01.006_bib0010","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/ecc.12282","article-title":"Clinical outcomes following neoadjuvant cisplatin-based chemotherapy for bladder cancer in elderly compared with younger patients","volume":"24","author":"Chau","year":"2015","journal-title":"Eur J Cancer Care (Engl)"},{"key":"10.1016\/j.urolonc.2024.01.006_bib0011","doi-asserted-by":"crossref","first-page":"e583","DOI":"10.1016\/j.clgc.2017.01.014","article-title":"Neoadjuvant chemotherapy in elderly patients with bladder cancer: oncologic outcomes from a single institution experience","volume":"15","author":"Leone","year":"2017","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.urolonc.2024.01.006_bib0012","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.juro.2017.08.086","article-title":"Treatment patterns and overall survival outcomes of octogenarians with muscle invasive cancer of the bladder: an analysis of the National Cancer Database","volume":"199","author":"Fischer-Valuck","year":"2018","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2024.01.006_bib0013","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/746298","article-title":"Neoadjuvant chemotherapy use in bladder cancer: a survey of current practice and opinions","volume":"2014","author":"Cowan","year":"2014","journal-title":"Adv Urol"},{"key":"10.1016\/j.urolonc.2024.01.006_bib0014","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/s41585-020-00404-6","article-title":"Defining cisplatin eligibility in patients with muscle-invasive bladder cancer","volume":"18","author":"Jiang","year":"2021","journal-title":"Nat Rev Urol"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143924000073?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143924000073?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,11]],"date-time":"2024-04-11T18:42:30Z","timestamp":1712860950000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143924000073"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":14,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S1078143924000073"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2024.01.006","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Age related trends in the utilization of neoadjuvant chemotherapy for muscle invasive bladder cancer","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2024.01.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}